Industry & policyReview
Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper
International Journal of Gynaecology and Obstetrics
- Menopause hormone therapy
- Dydrogesterone
- Sex hormone signalling (oestrogen, androgen)
- Ischemic heart disease
- Cardiovascular disease
- Humans
The paper
Benedetto C, Gulati M, Khadilkar SS et al.
International Journal of Gynaecology and Obstetrics · 22 Sep 2026
